Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244737 | SCV000313308 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000961874 | SCV001108930 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001162414 | SCV001324365 | benign | Severe early-childhood-onset retinal dystrophy | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000498988 | SCV001324366 | benign | Achromatopsia 3 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Breakthrough Genomics, |
RCV000961874 | SCV005271406 | benign | not provided | criteria provided, single submitter | not provided | ||
Molecular Genetics Laboratory, |
RCV000498988 | SCV000575812 | uncertain significance | Achromatopsia 3 | 2017-03-27 | no assertion criteria provided | research | |
Natera, |
RCV001272738 | SCV001454996 | benign | Achromatopsia | 2020-01-06 | no assertion criteria provided | clinical testing |